Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID‐19
Abstract Objectives Coronavirus disease 2019 (COVID‐19) is rapidly spreading worldwide.
Lianhua Qingwen capsule (LQC) has shown therapeutic effects in patients with COVID‐19 …
Lianhua Qingwen capsule (LQC) has shown therapeutic effects in patients with COVID‐19 …
Non-muscle invasive bladder cancer with variant histology: biological features and clinical implications
F Sanguedolce, B Calo, V Mancini, M Zanelli… - Oncology, 2021 - karger.com
Background: The most common bladder cancer (BC) histotype is pure urothelial carcinoma
(UC), which may undergo divergent differentiation in some cases. Variant histology (VH) …
(UC), which may undergo divergent differentiation in some cases. Variant histology (VH) …
Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous bladder cancer: an international multi-centre …
Purpose To compare cancer-specific mortality (CSM) and overall mortality (OM) between
immediate radical cystectomy (RC) and Bacillus Calmette–Guérin (BCG) immunotherapy for …
immediate radical cystectomy (RC) and Bacillus Calmette–Guérin (BCG) immunotherapy for …
Impact of variant histology on upstaging and survival in patients with nonmuscle invasive bladder cancer undergoing radical cystectomy
Introduction Variant histology (VH) of urothelial carcinoma is uncommon and frequently
presents at the muscle-invasive stage. VH is considering a significant risk factor for …
presents at the muscle-invasive stage. VH is considering a significant risk factor for …
Intravesical bacillus Calmette–Guérin treatment for T1 high-grade non-muscle invasive bladder cancer with divergent differentiation or variant morphologies
M Miyake, N Nishimura, K Iida, T Fujii, R Nishikawa… - Cancers, 2021 - mdpi.com
Simple Summary The 2016 World Health Organization classification system distinguishes
between urothelial carcinomas (UCs) with divergent differentiation (DD) and those with …
between urothelial carcinomas (UCs) with divergent differentiation (DD) and those with …
Comparative efficacy of Bacillus Calmette–Guérin instillation and radical cystectomy treatments for high-risk non-muscle-invasive urothelial cancer classified as high …
S Zhen, C Hao, Y Yanhang, L Yuxin… - Frontiers in …, 2024 - pmc.ncbi.nlm.nih.gov
Objective To compare the differential therapeutic effects of Bacillus Calmette-Guérin (BCG)
instillation and radical cystectomy (RC) for high-risk non-muscle–invasive urothelial cancer …
instillation and radical cystectomy (RC) for high-risk non-muscle–invasive urothelial cancer …
Pyuria as a Predictive Marker of Bacillus Calmette–Guérin Unresponsiveness in Non-Muscle Invasive Bladder Cancer
This study aims to investigate the clinical role of preoperative pyuria for predicting bacillus
Calmette–Guérin (BCG) unresponsiveness in non-muscle invasive bladder cancer (NMIBC) …
Calmette–Guérin (BCG) unresponsiveness in non-muscle invasive bladder cancer (NMIBC) …
[Retracted] Clinical Value Analysis of Xiaozheng Decoction Combined with Bladder Perfusion for Postoperative Treatment of Bladder Cancer and Its Effect on Serum …
X Yang, H Lv, W Jiang, J Zhang… - Journal of Healthcare …, 2022 - Wiley Online Library
Objective. To study the clinical value of Xiaozheng decoction combined with bladder
perfusion treating bladder cancer after the operation and its effect on serum miR‐143 and …
perfusion treating bladder cancer after the operation and its effect on serum miR‐143 and …
Clinical outcomes after intravesical bacillus Calmette–Guérin for the highest‐risk non‐muscle‐invasive bladder cancer newly defined in the Japanese Urological …
T Miyamoto, M Miyake, Y Toyoshima… - … Journal of Urology, 2021 - Wiley Online Library
Objective To assess the clinical outcomes of highest‐risk non‐muscle‐invasive bladder
cancer patients treated with intravesical bacillus Calmette–Guérin. Methods The medical …
cancer patients treated with intravesical bacillus Calmette–Guérin. Methods The medical …
Intra-arterial chemotherapy combined with BCG immunotherapy is more effective than intra-arterial chemotherapy plus intravesical chemotherapy or standard BCG …
S Luo, Y Wu, R Yang, J Liu, W Wusimanjiang… - … Oncology: Seminars and …, 2024 - Elsevier
Background Up to 45% of patients with high-risk non–muscle-invasive bladder cancer
(NMIBC) will not benefit from adjuvant intravesical instillation. We aimed to introduce intra …
(NMIBC) will not benefit from adjuvant intravesical instillation. We aimed to introduce intra …